Baird raised the firm’s price target on Patterson Companies (PDCO) to $31 from $25 and keeps a Neutral rating on the shares. The firm noted they announced today a definitive agreement to be acquired by Patient Square Capital for $31.35 cash per share.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDCO:
- M&A News: Patterson Companies Stock (PDCO) Rallies on Patient Square Deal
- Albertsons terminates Kroger deal, Macy’s reports Q3 beat: Morning Buzz
- Patterson Companies downgraded to Market Perform from Outperform at Leerink
- Patterson Companies to be acquired by Patient Square for $31.35 per share
- Patterson Companies price target lowered to $24 from $26 at Piper Sandler